Anaplastic Lymphoma Kinase (ALK)

specific

A T-cell peripheral lymphoma morphologically indistinguishable from anaplastic large cell lymphoma, ALK-positive. It is characterized by the absence of the translocation involving the ALK gene and lacks expression of ALK fusion protein.

5

Centers

0

Active Trials

$8M

Cancer Funding

Top Centers for Anaplastic Lymphoma Kinase (ALK)(5)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Siteman Cancer CenterSt. Louis, MO
NCI Comprehensive
High-Volume Research Center
74.0
2
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
67.0
3
Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolis, IN
NCI Comprehensive
Active Research Program
60.0
4
University of Colorado Cancer CenterAurora, CO
NCI Comprehensive
Active Research Program
53.0
5
Boston University Cancer CenterBoston, MA
46.0

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →